CORC

在结果中检索

CORC

浏览/检索结果: 共92条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
作者:  Qin, Yejun;  Liu, Jianping;  Li, Daiqiang;  Wang, Guoping;  Nie, Xiu
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 会议论文
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
作者:  Xi, Yangfeng;  Xu, Chen;  Liu, Yiqiang;  Yan, Xiaochu;  Huang, Chuansheng
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
作者:  Xi, Yangfeng;  Xu, Chen;  Liu, Yiqiang;  Yan, Xiaochu;  Huang, Chuansheng
收藏  |  浏览/下载：71/0  |  提交时间：2019/11/19
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
作者:  Xi, Yangfeng;  Xu, Chen;  Liu, Yiqiang;  Yan, Xiaochu;  Huang, Chuansheng
收藏  |  浏览/下载：75/0  |  提交时间：2019/11/19
EH-recommender: Recommending exception handling strategies based on program context 会议论文
作者:  Li, Yuhang;  Ying, Shi;  Jia, Xiangyang;  Xu, Yisen;  Zhao, Lily
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
MODERN PATHOLOGY, 2018-03-01
作者:  Xi, Yangfeng[1];  Xu, Chen[2];  Liu, Yiqiang[3];  Yan, Xiaochu[4];  Huang, Chuansheng[5]
收藏  |  浏览/下载：53/0  |  提交时间：2019/12/24
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
LABORATORY INVESTIGATION, 2018-03-01
作者:  Xi, Yangfeng;  Xu, Chen;  Liu, Yiqiang;  Yan, Xiaochu;  Huang, Chuansheng
收藏  |  浏览/下载：20/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace